[quote]Varqanir wrote:
apbt55 wrote:
take it or leave I would not steer you guys wrong. My daughters are 2 and 4 and will be getting the version without the adjuvant next week, my wife and I already signed up for a clinical trial and received the shot. No sever reactions. second shot 2.5 weeks.
Well and good, but will the version mass-produced by GlaxoSmithKline for mass injection of the populace have the squalene adjuvant, or will it not?
Would you allow your daughters and your wife to be injected with squalene? Why or why not?[/quote]
I personally would not allow my wife or daughters to be injected with most whole squalene adjuvants, I cannot speak for GSK, I can speak for our process. We use a derviatized form the squalene as an adjuvant that has shown no auto immune illness in animal models. But I have noe seen sufficient evidence in human models to say it is safe enough for my family.
The reason most people are skeptical about squalene is a study on gulf war syndrome, novartis produced the anthrax vaccine but had low yields so they used a squalene adjuvant. After vets returned home they started to show signs of auto immune disease similar to RA or agent oragne, swollen achy joints. The first study showed that 95% of the VA patience with antibodies to the whole squalene, while only 15% of the VA patience tested not shwoing gulf war syndrome had antibodies to squalene.
After this the department of defense and novartis funded studies and both showed no statistical significance between the 2 groups. But I would question these studies a little just by who performed them.
Moving on to the clinical trials now, we have a few formulations being tested. One includes the squalene derivative adjuvant. But I beleive we will not be releasing any pandemic vaccine using said adjuvant. If they do given the scenario and that our development group questioned these studies I know they will have investigated auto immune responses as well as initial signs similar to gulf war syndrome.
But to answer your question until I see that data no I would not accept a vaccine with a squalene adjuvant,
hope I don’t loose my job. But I think people should be able to make informed decisions.
I am not sure if GSK is still doing egg based vaccine, if so the immune response is sufficient and they really shouldn’t go to an adjuvant vaccine.
Novartis makes a cell line based recombinant vaccine which requires much more antigen to get an immune response and has much lower yields.
We use an egg base vaccine, have one of the more archaic processes but get the best immune response on the market, are first to market every year, have much higher yields. Rather than change the process, we strive to make is safer, understand it better and make sure tokeep as much antibody producing antigen in the vaccine as possible.
sorry that last little part was a sales pitch, but I take a little pride in the fact I help develop and validate methods that help our company understand the process and implications of our products. It is nice to know you help save lives even though some people think we make witches brew and poison.